Viking Therapeutics Inc
VKTX
Equity
ISIN null / Valor 24839858
NASDAQ (2026-03-31)
USD 32.54+8.76%
Viking Therapeutics Inc
UMushroom community rating:
About company
Viking Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies for metabolic and endocrine disorders.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
34.7%1Y
95.4%3Y
414%5Y
Performance
85.2%1Y
94.5%3Y
89.5%5Y
Volatility
3760 M
Market cap (USD)
2,762,816
Daily traded volume (Shares)
40.65 / 39.33
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
0.002022
0.002023
0.002024
Est dividend (USD)
0.00%2022
0.00%2023
0.00%2024
Est dividend yield
P/E ratio
00.002022
00.002023
00.002024
Est P/E ratio
EPS (USD)
0.002022
0.002023
0.002024
Est EPS (USD)
Ratings & reviews
Performance:
3.59
Innovation:
4.01
Society:
3.64
Nature:
3.46
George Williams
Exciting company, No real ROI yet, struggling with growth in the medium term.
Saahas Nair
decent
ola ho
n/a
EQUITIES OF THE SAME SECTOR
